Essity

Transaction in Own Shares • Jul 21, 2025

Press release

Stockholm, July 21, 2025

Buyback of Class B shares in Essity during week 29, 2025

Between July 14, 2025, and July 18, 2025, Essity Aktiebolag (publ) repurchased a total of 362,255 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on April 23, 2025. The buyback program will extend from April 24, 2025, until the 2026 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission's Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation.

0	Aggregated daily volume (no. of shares):	Weighted average price per day (SEK):	Total daily transaction value (SEK):
July 14, 2025	70,233	263.2687	18,490,151
July 15, 2025	70,636	261.7980	18,492,364
July 16, 2025	71,329	259.7055	18,524,534
July 17, 2025	74,703	249.0700	18,606,276
July 18, 2025	75,354	247.0971	18,619,755
Total accumulated during week 29 2025	362,255	255.9884	92,733,079
Total accumulated during the buyback program	3,461,353	268.8252	930,499,075

Class B shares in Essity were repurchased as follows:

All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity's holding of treasury shares amounted on July 18, 2025, to 4,243,853 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 58,973,654 Class A shares and 634,080,835 Class B shares.

For additional information, please contact: Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

About Essity

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.